#PD1i's are 15% of onc spend, but what % of life years gained? Checkpoint inhibitors were not found to be cost effective yet in a Nov18 #HEOR review: https://t.co/ozoaRhZpLo Lower prices will probably shift that equation.
147 followers
7,381 followers
RT @filimasini: A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors https://t.co/BU7JcQ7PVl
7,381 followers
RT @filimasini: A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors. - PubMed - NCBI https://t.c…
792 followers
A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors https://t.co/BU7JcQ7PVl